Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Nebbioso

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
European Journal of Medicinal Chemistry|May 20, 2014
Evaluation of a large library of (thiazol-2-yl)hydrazones and analogues as histone acetyltransferase inhibitors: enzyme and cellular studiesSimone Carradori, Dante Rotili, Celeste De Monte, et al.
Cell Death & Disease|April 20, 2019
BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibitionNunzio Del Gaudio, Antonella Di Costanzo, Ning Qing Liu, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activityElisa Giacomini, Angela Nebbioso, Alfonso Ciotta, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Correction to "Novel Antiproliferative Chimeric Compounds with Marked Histone Deacetylase Inhibitory Activity"Elisa Giacomini, Angela Nebbioso, Alfonso Ciotta, et al.
EMBO Reports|January 13, 2021
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexesAngela Nebbioso, Fabio Manzo, Marco Miceli, et al.
EMBO Reports|June 6, 2009
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexesAngela Nebbioso, Fabio Manzo, Marco Miceli, et al.
International Journal of Molecular Sciences|April 11, 2015
Antiproliferative, antibacterial and antifungal activity of the lichen Xanthoria parietina and its secondary metabolite parietinAdriana Basile, Daniela Rigano, Stefano Loppi, et al.
Journal of Molecular Endocrinology|July 20, 2010
HDACs class II-selective inhibition alters nuclear receptor-dependent differentiationAngela Nebbioso, Carmela Dell'Aversana, Anne Bugge, et al.
Plos One|December 19, 2013
HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or bIlaria Lepore, Carmela Dell'Aversana, Maxim Pilyugin, et al.
Molecular Pharmacology|August 2, 2007
Identification of two new synthetic histone deacetylase inhibitors that modulate globin gene expression in erythroid cells from healthy donors and patients with thalassemiaAntonello Mai, Katija Jelicic, Dante Rotili, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
European Journal of Medicinal Chemistry|May 20, 2014
Evaluation of a large library of (thiazol-2-yl)hydrazones and analogues as histone acetyltransferase inhibitors: enzyme and cellular studiesSimone Carradori, Dante Rotili, Celeste De Monte, et al.
Cell Death & Disease|April 20, 2019
BRD9 binds cell type-specific chromatin regions regulating leukemic cell survival via STAT5 inhibitionNunzio Del Gaudio, Antonella Di Costanzo, Ning Qing Liu, et al.
ACS Medicinal Chemistry Letters|September 16, 2014
Novel antiproliferative chimeric compounds with marked histone deacetylase inhibitory activityElisa Giacomini, Angela Nebbioso, Alfonso Ciotta, et al.
ACS Medicinal Chemistry Letters|August 14, 2024
Correction to "Novel Antiproliferative Chimeric Compounds with Marked Histone Deacetylase Inhibitory Activity"Elisa Giacomini, Angela Nebbioso, Alfonso Ciotta, et al.
EMBO Reports|January 13, 2021
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexesAngela Nebbioso, Fabio Manzo, Marco Miceli, et al.
EMBO Reports|June 6, 2009
Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexesAngela Nebbioso, Fabio Manzo, Marco Miceli, et al.
International Journal of Molecular Sciences|April 11, 2015
Antiproliferative, antibacterial and antifungal activity of the lichen Xanthoria parietina and its secondary metabolite parietinAdriana Basile, Daniela Rigano, Stefano Loppi, et al.
Journal of Molecular Endocrinology|July 20, 2010
HDACs class II-selective inhibition alters nuclear receptor-dependent differentiationAngela Nebbioso, Carmela Dell'Aversana, Anne Bugge, et al.
Plos One|December 19, 2013
HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or bIlaria Lepore, Carmela Dell'Aversana, Maxim Pilyugin, et al.
Molecular Pharmacology|August 2, 2007
Identification of two new synthetic histone deacetylase inhibitors that modulate globin gene expression in erythroid cells from healthy donors and patients with thalassemiaAntonello Mai, Katija Jelicic, Dante Rotili, et al.
Pageof 15